On the Record · Abbott Laboratories
Abbott Laboratories competitors, on the record
The companies whose own annual reports name Abbott Laboratories as a competitor, each with the sentence it appears in and the filing it came from.
Who Abbott Laboratories names
Abbott Laboratories’s annual reports for 2023 to 2025 describe its competition by kind of business and do not name competing companies.
Who names Abbott Laboratories
Companies whose own annual reports name Abbott Laboratories as a competitor.
Word for word“In addition, there are a number of companies, including Cardiovascular Systems Inc., Abbott Laboratories, Medtronic, Edwards Lifesciences, Boston Scientific, LivaNova, Terumo Heart, Teleflex, Getinge (Maquet Cardiovascular) and several early-stage companies, that are developing medical devices that provide circulatory support and oxygenation, including implantable left ventricular assist devices, miniaturized rotary ventricular assist devices and cardiopulmonary bypass devices that directly and indirectly compete with our products.” 10-K for 2022
Word for word“Major competitors for our products in the Clinical Diagnostics segment include Abbott Laboratories, Becton Dickinson, bioMérieux, Danaher, DiaSorin, Werfen, QuidelOrtho, Roche, Siemens Healthineers, Thermo Fisher Scientific and Tosoh.” 10-K for 2025
Word for word“In TMTT, our primary competitor is Abbott, and there are a considerable number of large and small companies with development efforts in these fields.” 10-K for 2025
Word for word“Some of the medical device companies that we expect to compete with include Abbott Laboratories, DexCom, Medtronic, and Senseonics.” 10-K for 2025
Word for word“Our main competitors in vascular access closure include Terumo BCT, Abbott Laboratories, Cordis, and Teleflex, where we compete primarily based on clinical and economic value, ease of use, workflow improvements and patient satisfaction.” 10-K for 2026
Word for word“In our Diagnostics business, our primary competitors include Roche Diagnostics, Abbott Laboratories and Cepheid in the molecular diagnostics field, and Becton Dickinson in the cytology field, as well as a wide range of diagnostics companies that sell a single or limited number of assays or products in only a specific market segment (i.e., Cytology, Acute Care, or Oncology Services).” 10-K for 2025
Word for word“Our primary competitors in our cardiac intervention market are BD, Teleflex, Medtronic, Abbott Laboratories, Terumo Corporation, Edwards Lifesciences Corporation, Cook Medical, and Boston Scientific.” 10-K for 2025
Ortho Clinical Diagnostics Holdings
Word for word“In the Clinical Laboratories market, our principal competitors include: Abbott Laboratories, Danaher Corporation, Roche, and Siemens Healthineers.” 10-K for 2022
Word for word“These competitors include, among others, Abbott Laboratories, Beckman Coulter Primary Care Diagnostics, Thermo Fisher Scientific, Becton Dickinson and Company, Meridian Bioscience, Inc., and Danaher Corporation.” 10-K for 2021
Word for word“Some of our principal competitors include, among others, Abbott Laboratories, bioMérieux, Bio-Rad, Danaher, Diasorin, Hologic, Qiagen, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Waters Corporation (acquired BD Diagnostics division) and Wermerson Immuncor.” 10-K for 2025
Read from Abbott Laboratories’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-20. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.